Ginkgo Bioworks Holdings, Inc. (DNA) has 6 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $35K. Most recent filing: Sept. 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 16, 2026 filed Sept. 15, 2026 | HENRY CHRISTIAN O Director | −$35,405 | 5,000 | −21% | No | |
|
|
||||||
| Aug. 25, 2026 filed Aug. 21, 2026 | Coen Steven P. See remarks | — | +413 | +1% | No | |
|
|
||||||
| July 30, 2026 filed July 28, 2026 | Canton Barry 10% Owner | $0 | 319,332 | 0% | No | |
|
|
||||||
| July 30, 2026 filed July 28, 2026 | Shetty Reshma P. See remarks | $0 | 319,332 | 0% | No | |
|
|
||||||
| July 30, 2026 filed July 28, 2026 | Kelly Jason R See remarks | $0 | 383,725 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free